A detailed history of Hsbc Holdings PLC transactions in Mannkind Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 20,920 shares of MNKD stock, worth $143,302. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,920
Previous 28,078 25.49%
Holding current value
$143,302
Previous $146,000 10.27%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.01 - $6.7 $35,861 - $47,958
-7,158 Reduced 25.49%
20,920 $131,000
Q2 2024

Aug 12, 2024

SELL
$4.05 - $5.43 $12,312 - $16,507
-3,040 Reduced 9.77%
28,078 $146,000
Q1 2024

May 15, 2024

BUY
$3.25 - $5.27 $101,133 - $163,991
31,118 New
31,118 $140,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.76B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.